High Throughput Screening Market by Application (Toxicology Assessment, Target Identification and Validation, Primary and Secondary Screening, and Others); by Technology (Bioinformatics, Label-Free Technology, Lab-on-a-Chip, Cell-Based Assays, Ultra-High-Throughput Screening); by Product and Services (Software, Instruments, Reagent and Assay Kits, Consumables and Accessories and Services); by End Users (CROs, Government and Academic Institutes, Biotechnology and Pharmaceutical Companies, and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for high throughput screening market was valued at approximately USD 13.9 billion in 2018, and is expected to generate revenue of around USD 21.8 billion by end of 2025, growing at a CAGR of around 6.7% between 2019 and 2025.

07-Nov-2019 | Number of pages: 126 | Report Code: ZMR-5018 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the high throughput screening market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the high throughput screening market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the high throughput screening market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the high throughput screening market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the high throughput screening market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the high throughput screening market on global and regional basis.

The study provides a crucial view on the high throughput screening by segmenting the market based on application, technology, product and services, end user and region. All the segments of high throughput screening market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

High throughput screening (HTS) is used for carrying out chemical, genetic and pharmacological tests. These tests are used to detect drugs presence, drug trails, and drug design and drug interactions. It uses many devices such as detectors, control software, and instruments to analyze the bimolecular and genetic interactions. It is a process by which compounds are tested for activators (agonists) or inhibitors (antagonists). Receptors and metabolic enzymes can also be tested. The numbers of leads, i.e. those compounds that produce the desired effect and which are active at low concentration, are detected. Many drugs such as mevastatin and cyclosporin A have been detected using HTS tests. The main task of the HTS is to detect lead compounds. Directions are then given for its optimization.

The increased penetration of the high throughput screening is largely due to the increasing number of drug screening requirements, stem cell research, toxicological studies, R&D programs initiated by governments and research centers, technological advancements in HTS found by biotechnology companies, increase in research and venture capital investments. However, the high cost of techniques and the lack of trained professionals to handle HTS software may inhibit the growth of this market.

Based on product and services market is segmented into software, instruments, reagent and assay kits, service, accessories and consumables. Reagents and assay kits are the most used products and services of products for HTS tests due to the increasing number of assays development, continuous use of reagents for HTS tests, the rising R&D expenditure, high incidence of diseases and increased continued government support for research in drugs detection and recovery.

Based on technology market is segmented into lab-on-a-chip, cell-based assays, ultra high throughput screening, label-free technology and bioinformatics. Cell based assays segment is further split into perfusion cell culture, 2D cell culture, and 3D Cell culture. Label-free technology segment will grow at a highest CAGR over the forecast period. This high growth is attributed to advantages offered by label-free technology. Label-free technology can be used to study diverse cell types and targets. Also probability of drug attrition due to toxicity can be reduced; complex biological pathways can be studied using simple methods using label-free technology. Cell based assay technology held largest market share in 2018.

These high throughput screenings are used for various applications such as primary and secondary screening, target identification and validation, toxicology assessment and other applications. Target identification & validation segment held largest market share in 2018 as a result of increase in the number of prospective drug targets for screening.

Contract research organizations (CROs), academic and government institutes, pharmaceutical and biotechnology companies and others are significant end users for the high throughput screening market. Pharmaceutical and biotechnology companies held significant market share in 2018 in terms of revenue. Large share is attributed to the increasing use of HTS technologies by biotech and pharmaceutical companies for drug discovery and toxicology studies.

North America is seen to be the significant contributor to the market share, mainly due to the emphasis placed on research and development in pharmaceutical companies, the adoption of drug detection techniques, government support and funding and large number of companies producing HTS products and services. European markets have a large share of the market due to advancements in chemical testing, development of software and hardware that can automate testing, government initiatives for drug testing, R&D by various research centers and increase in utilization of data processing software for HTS. Asia Pacific region has experienced rising popularity of high throughput screening techniques. The pharmaceutical industry has shifted from traditional approaches of using only one compound and low throughput, to automated processes using robotic systems and high throughput screening. Compounds found in different areas of biology are tested. The techniques used are simple, efficient and of particularly low cost. Middle East and Africa region will experience sluggish growth in the years to come. Latin America is projected to exhibit moderate growth for high throughput screening market during the forecast period.

Major players included in the report are Axxam, Corning, Thermo Fisher Scientific, Bio-Rad, Danaher, Hamilton, Agilent, Tecan, Merck Group, PerkinElmer, BioTek  and Aurora Biomed among others.

The report segment of global high throughput screening market as follows:

Global High Throughput Screening Market: By Product and Services

  • Reagents & Assay Kits
  • Instruments
  • Consumables & Accessories
  • Software
  • Services

Global High Throughput Screening Market: By Technology

  • Cell-based Assays
    • 2D Cell Culture
    • 3D Cell Culture
    • Perfusion Cell Culture
  • Lab-on-a-chip (LOC)
  • Ultra-high-throughput Screening
  • Bioinformatics
  • Label-free Technology

Global High Throughput Screening Market: By Application

  • Target Identification & Validation
  • Primary and Secondary Screening
  • Toxicology Assessment
  • Other Applications

Global High Throughput Screening Market: By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations
  • Other End Users

Global High Throughput Screening Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Global Remdesivir Market - by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.